Treatment of canine fucosidosis by intracisternal enzyme infusion

This publication has 25 references indexed in Scilit:

• Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I
  Molecular Genetics and Metabolism, 2010
• Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen
  Molecular Genetics and Metabolism, 2010
• Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease
  Experimental Neurology, 2009
• Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis
  Molecular Therapy, 2008
• Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid
  Molecular Genetics and Metabolism, 2007
• Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice
  Molecular Genetics and Metabolism, 2007
• Recombinant Canine α--Fucosidase: Expression, Purification, and Characterization
  Molecular Genetics and Metabolism, 2000
• Canine fucosidosis: a model for retroviral gene transfer into haematopoietic stem cells
  Neuromuscular Disorders, 1997
• Biochemical evidence for a case of canine fucosidosis
  Biochemical Society Transactions, 1984
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976